Market Introduction
The closed system drug transfer devices provide protection against hazardous drugs or vapors during drug preparation and administration. It comprises components which enables filtering of dangerous vapors out of the system. Closed system drug transfer devices play a major role in protection of healthcare professionals from antineoplastic as well as other harmful medications.
Market Overview and Dynamics
The Europe closed systems drug transfer devices market is expected to reach US$ 487.58 million by 2027 from US$ 112.01 million in 2019. The market is anticipated to grow at a CAGR of 20.3% during 2019–2027. The growing adoption of chemotherapy and improvement of regulatory guidelines regarding hazardous drugs are the major factors expected to boost the growth of the closed systems drug transfer devices market in Europe. However, the market is likely to get impacted by the risk factor such as lack of standards and product safety issues during the forecast period.
Key Market Segments
In terms of closing mechanism, the push-to-turn systems segment accounted for the largest share of the Europe closed systems drug transfer devices market in 2019. In terms of type, membrane-to-membrane systems segment accounted for the largest share of the Europe closed systems drug transfer devices market in 2019. In terms of technology, the diaphragm-based devices segment accounted for the largest share of the Europe closed systems drug transfer devices market in 2019. In terms of component, the vial access devices segment accounted for the largest share of the Europe closed systems drug transfer devices market in 2019. In terms of end-user, the hospitals and clinics segment accounted for the largest share of the Europe closed systems drug transfer devices market in 2019.
Major Sources and Companies Listed
Several major primary and secondary sources associated with the Europe closed systems drug transfer devices market report are the World Health Organization (WHO), Cancer Research UK, European Federation of Pharmaceutical Industries and Associations (EFPIA), and Globocan Statistics, among others.
Reasons to buy report
EUROPE CLOSED SYSTEMS DRUG TRANSFER DEVICES MARKET SEGMENTATION
By Type
By Technology
By Component
By End User
By Country
Company Profiles
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 112.01 Million |
| Market Size by 2027 | US$ 487.58 Million |
| CAGR (2019 - 2027) | 20.3% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Closing Mechanism
|
|
Regions and Countries Covered
|
|
| Europe | UK, Germany, France, Russia, Italy, Rest of Europe |
| Market leaders and key company profiles |
|
The Europe Closed Systems Drug Transfer Devices Market is valued at US$ 112.01 Million in 2019, it is projected to reach US$ 487.58 Million by 2027.
As per our report Europe Closed Systems Drug Transfer Devices Market, the market size is valued at US$ 112.01 Million in 2019, projecting it to reach US$ 487.58 Million by 2027. This translates to a CAGR of approximately 20.3% during the forecast period.
The Europe Closed Systems Drug Transfer Devices Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Closed Systems Drug Transfer Devices Market report:
The Europe Closed Systems Drug Transfer Devices Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Closed Systems Drug Transfer Devices Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Closed Systems Drug Transfer Devices Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)